Cerus Past Earnings Performance

Past criteria checks 0/6

Cerus has been growing earnings at an average annual rate of 17.6%, while the Medical Equipment industry saw earnings growing at 12% annually. Revenues have been growing at an average rate of 17.9% per year.

Key information

17.6%

Earnings growth rate

22.9%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate17.9%
Return on equity-36.5%
Net Margin-11.2%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Cerus Corporation (NASDAQ:CERS) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Sep 26
Cerus Corporation (NASDAQ:CERS) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Analysts Are Upgrading Cerus Corporation (NASDAQ:CERS) After Its Latest Results

Aug 04
Analysts Are Upgrading Cerus Corporation (NASDAQ:CERS) After Its Latest Results

Cerus Corporation's (NASDAQ:CERS) 30% Jump Shows Its Popularity With Investors

Jul 18
Cerus Corporation's (NASDAQ:CERS) 30% Jump Shows Its Popularity With Investors

Does Cerus (NASDAQ:CERS) Have A Healthy Balance Sheet?

Jul 12
Does Cerus (NASDAQ:CERS) Have A Healthy Balance Sheet?

The Cerus Corporation (NASDAQ:CERS) First-Quarter Results Are Out And Analysts Have Published New Forecasts

May 05
The Cerus Corporation (NASDAQ:CERS) First-Quarter Results Are Out And Analysts Have Published New Forecasts

Here's Why Cerus (NASDAQ:CERS) Can Afford Some Debt

Apr 12
Here's Why Cerus (NASDAQ:CERS) Can Afford Some Debt

Cerus Corporation (NASDAQ:CERS) Stock Rockets 29% But Many Are Still Ignoring The Company

Mar 07
Cerus Corporation (NASDAQ:CERS) Stock Rockets 29% But Many Are Still Ignoring The Company

Slammed 29% Cerus Corporation (NASDAQ:CERS) Screens Well Here But There Might Be A Catch

Jan 18
Slammed 29% Cerus Corporation (NASDAQ:CERS) Screens Well Here But There Might Be A Catch

Health Check: How Prudently Does Cerus (NASDAQ:CERS) Use Debt?

Oct 06
Health Check: How Prudently Does Cerus (NASDAQ:CERS) Use Debt?

Is Cerus (NASDAQ:CERS) A Risky Investment?

Jul 07
Is Cerus (NASDAQ:CERS) A Risky Investment?

Slammed 32% Cerus Corporation (NASDAQ:CERS) Screens Well Here But There Might Be A Catch

May 12
Slammed 32% Cerus Corporation (NASDAQ:CERS) Screens Well Here But There Might Be A Catch

Cerus: Technical Support Fades, Investment Case Weakens (Technical Analysis)

Sep 29

Cerus GAAP EPS of -$0.05 beats by $0.02, revenue of $47.63M beats by $4.87M

Aug 04

Cerus: Lacks Conviction Against Macro Backdrop, Technicals Supportive Of Near-Term Upside

Jul 14

Is Cerus (NASDAQ:CERS) Using Debt In A Risky Way?

Jul 06
Is Cerus (NASDAQ:CERS) Using Debt In A Risky Way?

Is Cerus (NASDAQ:CERS) Using Debt Sensibly?

Mar 17
Is Cerus (NASDAQ:CERS) Using Debt Sensibly?

Cerus Corporation: Outperforming And Gaining Momentum

Jan 28

Revenue & Expenses Breakdown

How Cerus makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqGM:CERS Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24176-207458
30 Jun 24170-247261
31 Mar 24164-327465
31 Dec 23156-377668
30 Sep 23154-508172
30 Jun 23153-518571
31 Mar 23156-468467
31 Dec 22162-438364
30 Sep 22158-388261
30 Jun 22154-428360
31 Mar 22145-498362
31 Dec 21131-548163
30 Sep 21119-607865
30 Jun 21107-617466
31 Mar 2197-617064
31 Dec 2092-606764
30 Sep 2085-626564
30 Jun 2079-666564
31 Mar 2076-696663
31 Dec 1975-716660
30 Sep 1970-716456
30 Jun 1968-676251
31 Mar 1965-625947
31 Dec 1861-585743
30 Sep 1861-535538
30 Jun 1856-525335
31 Mar 1850-565334
31 Dec 1744-615334
30 Sep 1737-635235
30 Jun 1737-645234
31 Mar 1737-655134
31 Dec 1637-634931
30 Sep 1637-644830
30 Jun 1635-654630
31 Mar 1634-634627
31 Dec 1534-564626
30 Sep 1534-614524
30 Jun 1536-564323
31 Mar 1536-484123
31 Dec 1436-393822
30 Sep 1436-243421
30 Jun 1436-343318
31 Mar 1438-333117
31 Dec 1340-433015

Quality Earnings: CERS is currently unprofitable.

Growing Profit Margin: CERS is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: CERS is unprofitable, but has reduced losses over the past 5 years at a rate of 17.6% per year.

Accelerating Growth: Unable to compare CERS's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: CERS is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.4%).


Return on Equity

High ROE: CERS has a negative Return on Equity (-36.45%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies